Lynestrenolum
Orgametril contains lynestrenol, a synthetic progestogen similar to natural progesterone.
Progestogens, including Orgametril, are often used in menstrual cycle disorders.
Orgametril is indicated for use in adult patients over 18 years of age.
Indications for use of Orgametril:
Before starting Orgametril, discuss it with your doctor or pharmacist.
Patient with the following diseases should be under close medical supervision.
Tell your doctor about:
The safety and efficacy of Orgametril in adolescents under 18 years of age have not been established. There are no available data.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take, including those available without a prescription.
Taking other medicines may affect the effectiveness of Orgametril, and Orgametril may affect the effectiveness of other medicines. Before taking any medicine, consult your doctor or pharmacist.
Tell your doctor or pharmacist about taking or planning to take other medicines, such as:
If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Taking Orgametril during pregnancy or if you think you may be pregnant is contraindicated.
Some patients may experience dizziness. Do not drive in this case.
If you have been diagnosed with an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Indications | Dosage |
Frequent menstruation: | 1 tablet per day from the 14th to the 25th day of the cycle. |
Heavy menstrual bleeding and uterine hemorrhage: | 2 tablets per day for 10 days. Bleeding usually stops within a few days of starting treatment. The treatment is repeated for the next 3 menstrual cycles, taking 1 tablet per day from the 14th to the 25th day of each cycle. If symptoms do not improve during or after treatment, additional diagnostic tests are necessary. |
Selected cases of primary and secondary absence and scanty menstrual bleeding: | Treatment should start with the administration of estrogens, e.g., 0.02 to 0.05 mg of ethinyl estradiol per day for 25 days. At the same time, from the 14th to the 25th day of the cycle, 1 tablet of Orgametril per day is administered. Usually, within 3 days after the end of treatment, bleeding occurs. The treatment is repeated (second cycle) starting the administration of estrogens on the 5th day of bleeding and continuing until the 25th day of the cycle, and additionally, from the 14th to the 25th day of the cycle, 1 tablet of Orgametril per day is administered. This treatment should be continued for at least 1 cycle. |
Endometriosis: | 1 to 2 tablets per day for at least 6 months. |
Selected cases of endometrial cancer: | 6 to 10 tablets per day for a longer period. |
Benign breast diseases: | 1 tablet per day from the 14th to the 25th day of the cycle, for at least 3 to 4 months. |
Inhibition of menstrual bleeding, ovulation, painful ovulation, painful menstruation: | Treatment should start on the first day of the cycle, but no later than the 5th day of the cycle, taking 1 tablet per day. The treatment can be continued for many months (without interruption). If, despite taking the medicine, bleeding occurs, the dose of Orgametril should be increased to 2 to 3 tablets per day for 3 to 5 days. |
Delaying the date of menstrual bleeding: | Treatment should start preferably 2 weeks before the expected date of menstruation, taking 1 tablet per day. If treatment is started less than 1 week before the expected date of menstruation, the dose of Orgametril should be increased to 2 to 3 tablets per day. However, in this case, it is not recommended to delay the date of menstruation by more than 1 week. The later the treatment is started, the higher the risk of intermenstrual bleeding. Therefore, treatment should be started no later than 3 days before the expected date of menstruation. |
Supplementary treatment to estrogen therapy during the perimenopausal and postmenopausal period to prevent endometrial hyperplasia: | 1 tablet per day for 12 to 15 days a month, e.g., for the first 2 weeks of the calendar month. Estrogens can be administered daily without interruption in the smallest effective dose. |
NOTE:the first day of menstrual bleeding is the first day of the cycle.
Orgametril should be taken orally at the same time every day, with a small amount of water or other liquid.
If you feel that the effect of Orgametril is too strong or too weak, consult your doctor or pharmacist.
If you have taken more tablets than recommended, inform your doctor or pharmacist.
Nausea and vomiting may occur.
Do not take a double dose to make up for a missed dose.
If you miss a dose, take the medicine as soon as possible, unless the interval is more than 24 hours. In this case, skip the missed dose.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Lynestrenol affects the endometrium, and it may be used to treat menstrual cycle disorders. Cycles are normalized by taking Orgametril for several days a month. A few days after stopping Orgametril, usually within 3 days, the endometrium is shed, and bleeding (similar to menstruation) occurs.
Like all medicines, Orgametril can cause side effects, although not everybody gets them.
Depending on the dose and the patient's sensitivity, Orgametril may cause side effects. The following side effects have been observed:
Very common (occurring in at least 1 in 10 people):
Common (occurring less often than 1 in 10 people):
Uncommon (occurring less often than 1 in 100 people):
If you experience any of the above side effects, tell your doctor or pharmacist, especially if you experience vaginal bleeding.
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 22 49-21-301
fax: + 48 22 49-21-309
website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
Store below 30°C. Store the blister in the original packaging to protect from light and moisture.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White, round tablets with a notch, with the inscription Organon and a star on one side, and the code TT above and "4" below the dividing line on the other side of the tablet.
The pack contains 30 tablets.
For more detailed information, contact the marketing authorization holder or the parallel importer.
N.V. Organon, Kloosterstraat 6, 5349 AB Oss, Netherlands
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Marketing authorization number in the Czech Republic, the country of export: 56/112/70-C
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.